Strota / NATCOPHARM / Quarterly results

Natco Pharma Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Natco Pharma's quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹735 crore (-44.7% year on year), net profit ₹206 crore (-57.0% year on year), EPS ₹11.53. Announced 14 Aug 2026, 4:04 pm IST. The shares fell 1.48% on 17 Aug 2026, 1.16 points worse than the Nifty 50.
Revenue
₹735 cr
YoY -44.7% · QoQ -0.5%
Net profit
₹206 cr
YoY -57.0% · QoQ -22.9%
EPS (basic)
₹11.53
YoY -57.0%
Share price reaction
-1.5%
17 Aug 2026 · vs Nifty -1.2%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹1,221 cr Q4 FY25 net profit: ₹407 cr Q4 FY25 Q1 FY26 Revenue: ₹1,329 cr Q1 FY26 net profit: ₹481 cr Q1 FY26 Q2 FY26 Revenue: ₹1,363 cr Q2 FY26 net profit: ₹518 cr Q2 FY26 Q3 FY26 Revenue: ₹647 cr Q3 FY26 net profit: ₹152 cr Q3 FY26 Q4 FY26 Revenue: ₹739 cr Q4 FY26 net profit: ₹268 cr Q4 FY26 Q1 FY27 Revenue: ₹735 cr Q1 FY27 net profit: ₹206 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2714 Aug 2026, 4:04 pm IST 735-44.7%206-57.0% 28.1%11.53 -1.5%
Q4 FY2629 May 2026, 5:18 pm IST 739-39.5%268-34.1% 36.2%14.96 -8.1%
Q3 FY2612 Feb 2026, 4:48 pm IST 647—152— 23.4%8.46 -1.9%
Q2 FY2614 Nov 2025, 3:53 pm IST 1,363—518— 38.0%28.94 +1.0%
Q1 FY2612 Aug 2025, 3:34 pm IST 1,329—481— 36.2%26.84 +1.8%
Q4 FY2528 May 2025, 5:55 pm IST 1,221—407— 33.3%22.7 +3.6%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How NATCOPHARM shares react to results

Across the last 6 results here, the shares rose on 3 and fell on 3. The average move was -0.84%, and the average size of the move either way 3.00%; the biggest was -8.13% after the Q4 FY26 results.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Natco Pharma's Q1 FY27 results?

For the quarter to 30 Jun 2026, Natco Pharma reported revenue of ₹735 crore (-44.7% year on year) and net profit of ₹206 crore (-57.0%), with basic EPS of ₹11.53.

How did Natco Pharma shares react to the Q1 results?

They fell 1.48% on 17 Aug 2026, the first session that could trade on the results (announced after the close); that was 1.16 points worse than the Nifty 50 that day.

When is Natco Pharma's next results date?

No results date has been announced to NSE yet. Companies give advance notice of the board meeting; the results calendar lists every announced date.

Do Natco Pharma shares usually rise after results?

In the last 6 results here they rose 3 times and fell 3 times, moving 3.00% on average either way.

About this data

From Natco Pharma's Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See NATCOPHARM stock page for price, open interest and deals, all results declared this week and the results calendar, and NATCOPHARM dividend history.